The NF-κB is a key regulator that shares in "the inflammation–fibrosis–cancer process", and the NF-κB signaling pathway seems to have an essential effect on liver homeostasis, pathophysiology, and regulation of the inflammation–fibrosis–cancer axis [20]. Here, NFKB1 is linked to cancer.